SLNO SOLENO THERAPEUTICS INC

8-K Current Report

Filed: February 25, 2026

Health Care

Pharmaceutical Preparations

SOLENO THERAPEUTICS INC (SLNO) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q1 2025 earnings results disclosed via press release attached as exhibit — full financials in accompanying exhibit
• Filing structured as Reg FD-style disclosure; not "filed" under Exchange Act Section 18, limiting shareholder litigation exposure

+1 more insights

Other SOLENO THERAPEUTICS INC 8-K Filings

8-K Mar 16, 2026

8-K Feb 26, 2026

Get deeper insights on SOLENO THERAPEUTICS INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.